wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34547528-5E59FDED-CDEA-40F4-BC19-4C49FE514EC9
Q34547528-5E59FDED-CDEA-40F4-BC19-4C49FE514EC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34547528-5E59FDED-CDEA-40F4-BC19-4C49FE514EC9
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childho
P2860
Q34547528-5E59FDED-CDEA-40F4-BC19-4C49FE514EC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34547528-5E59FDED-CDEA-40F4-BC19-4C49FE514EC9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
812199f3f7618719db578dd2bb65ad0ac53ef1f8
P2860
Down-modulation of survivin expression and inhibition of tumor growth in vivo by EZN-3042, a locked nucleic acid antisense oligonucleotide.